EQUITY, RESTATED (Details Narrative) (USD $)	9 Months Ended
	Nov. 30, 2013
Advisory And Clinical [Member]
Restricted stock issued	$ 153,013
Director [Member]
Common stock issued	150,000
Fair value	375,000
Advisor [Member]
Common stock issued	100,000
Fair value	250,000
Stock compensation expense	250,000
Consultant [Member]
Common stock issued	12,000
Fair value	34,200
Stock compensation expense	$ 34,200